Fact CheckerSign in

NCT07803315Recruiting

Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy

Perfusion Mapping and Tissue Characterization Using Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

The goal of this prospective observational study is to learn about the use of a novel imaging technique called hyperspectral imaging in adult participants who are having surgery for removing a tumor from their kidney. Hyperspectral imaging works by shining light on a structure (in this case, the kidney tissue with the tumor) and capturing how it reflects hundreds of very narrow color bands, including ones the human eye can't see. These patterns depend on the composition of the tissue and for example how well blood is flowing through the tissue. By studying these patterns, the investigators want to understand if this technique can be helpful for the surgery where only the part of the kidney with the tumor is removed. The main questions it aims to answer are: * Can hyperspectral imaging show the areas of blood flow in the kidney during surgery? * Is there a connection between the detected patterns of light and the type of kidney tumor? The imaging will happen during the already planned surgery and the participant does not need to undergo any additional tests.

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
14 Aug 2025
Start date
1 Sept 2026
Primary completion date
Aug 2028
Lead sponsor
University of Leipzig
NCT number
NCT07803315

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 1 Sept 2026 to the primary completion date, Aug 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • patients with a previous surgery on the affected kidney
  • current immunosuppression (e.g., organ transplantation, leukemia)

Other illness

  • previous malignancy with ongoing or planned nephrotoxic chemotherapy

Other

  • patients with a fully intrarenal/endophytic tumor without an exophytic component
  • pregnancy, lactation, or women who wish to have children
  • inability to give informed consent

Who the study is looking for

  • Patients with a kidney tumor ≤7cm
  • planned robot-assisted partial nephrectomy
  • age ≥ 18 years

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Leipzig
Coordinator of this site? Confirm its status
LeipzigGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.